Lipoamide Dehydrogenase (DLD) Human shRNA Plasmid Kit (Locus ID 1738)

Specifications

Product Data
Product Name	Lipoamide Dehydrogenase (DLD) Human shRNA Plasmid Kit (Locus ID 1738)
Locus ID	1738
UniProt ID	P09622
Synonyms	DLDD; DLDH; E3; GCSL; LAD; OGDC-E3; PHE3
Vector	pRS
Format	Retroviral plasmids
Kit Components	DLD - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 1738). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.
RefSeq	NM_000108, NM_001289750, NM_001289751, NM_001289752, NM_000108.1, NM_000108.2, NM_000108.3, NM_000108.4, NM_001289750.1, NM_001289752.1, NM_001289751.1, BC018648, BC018648.2, BC018696, NM_000108.5
Summary	This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In homodimeric form, the encoded protein functions as a dehydrogenase and is found in several multi-enzyme complexes that regulate energy metabolism. However, as a monomer, this protein can function as a protease. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.